Manulife (Manufacturers Life Insurance)’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $838K | Buy |
|
|||||
|
2025
Q3 | $910K | Buy |
|
|||||
|
2025
Q2 | $924K | Buy |
|
|||||
|
2025
Q1 | $727K | Buy |
|
|||||
|
2024
Q4 | $843K | Buy |
|
|||||
|
2024
Q3 | $821K | Buy |
|
|||||
|
2024
Q2 | $837K | Buy |
|
|||||
|
2024
Q1 | $839K | Buy |
|
|||||
|
2023
Q4 | $712K | Sell |
|
|||||
|
2023
Q3 | $572K | Buy |
|
|||||
|
2023
Q2 | $424K | Buy |
|
|||||
|
2023
Q1 | $375K | Buy |
|
|||||
|
2022
Q4 | $430K | Buy |
|
|||||
|
2022
Q3 | $578K | Sell |
|
|||||
|
2022
Q2 | $451K | Sell |
|
|||||
|
2022
Q1 | $607K | Buy |
|
|||||
|
2021
Q4 | $1K | Buy |
|
|||||
|
2021
Q3 | $389K | Buy |
|
|||||
|
2021
Q2 | $520K | Buy |
|